Alexia Verroken

Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis

Anaïs Scohy, Ahalieyah Anantharajah, Monique Bodéus et al. · Journal of Clinical Virology · 2020 · 620 citations · Full text

Point-of-care Testing, Viral Diagnostics, Low Performance +9

Evaluation of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of<i>Nocardia</i>Species

Alexia Verroken, Michèle Janssens, C. Berhin et al. · Journal of Clinical Microbiology · 2010 · 149 citations · Full text

Evaluation of Chilblains as a Manifestation of the COVID-19 Pandemic

Anne Herman, C. Peeters, Alexia Verroken et al. · JAMA Dermatology · 2020 · 137 citations · Full text

Clinical Impact of MALDI-TOF MS Identification and Rapid Susceptibility Testing on Adequate Antimicrobial Treatment in Sepsis with Positive Blood Cultures

Alexia Verroken, L. Defourny, Olivier le Polain de Waroux et al. · PLoS ONE · 2016 · 94 citations · Full text

Rapid Susceptibility, Rapid Susceptibility Testing, Clinical Impact +16

Reducing time to identification of positive blood cultures with MALDI-TOF MS analysis after a 5-h subculture

Alexia Verroken, L. Defourny, L. Lechgar et al. · European Journal of Clinical Microbiology & Infectious Diseases · 2014 · 92 citations

Laboratory Hematology, Health Sciences, Medicine +10